Jasper Therapeutics
JSPR
Jasper Therapeutics (JSPR) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$1.13
- EPS estimate
- −$1.21
- EPS surprise
- +6.99%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 10, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 10, 2025 | −$1.21 | −$1.13 | +6.99% | $0.00 | SEC |
| Q2 2025 | Aug 13, 2025 | −$1.33 | −$1.74 | −31.19% | $0.00 | SEC |
| Q1 2025 | May 12, 2025 | −$1.35 | −$1.41 | −4.63% | $0.00 | SEC |
| Q4 2024 | Feb 27, 2025 | −$1.25 | −$1.62 | −29.17% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$1.07 | −$1.24 | −15.75% | $0.00 | SEC |
| Q2 2024 | Aug 13, 2024 | −$1.09 | −$0.97 | +10.89% | $0.00 | SEC |
| Q1 2024 | May 14, 2024 | −$1.23 | −$1.03 | +15.92% | $0.00 | SEC |
| Q4 2023 | Mar 4, 2024 | −$1.61 | −$1.50 | +6.76% | $0.00 | SEC |
| Q3 2023 | Nov 9, 2023 | −$1.55 | −$1.60 | −3.09% | $0.00 | SEC |
| Q2 2023 | Aug 11, 2023 | −$1.48 | −$1.50 | −1.03% | $0.00 | SEC |
| Q1 2023 | May 12, 2023 | −$1.62 | −$1.60 | +1.42% | $0.00 | SEC |
| Q4 2022 | Mar 8, 2023 | −$3.74 | −$3.60 | +3.75% | $0.00 | SEC |
| Q3 2022 | Nov 10, 2022 | −$3.40 | −$3.04 | +10.71% | $0.00 | — |
| Q2 2022 | Aug 12, 2022 | −$3.13 | −$2.90 | +7.45% | $0.00 | — |
| Q1 2022 | May 12, 2022 | −$3.50 | −$0.60 | +82.86% | $0.00 | — |
| Q4 2021 | Mar 18, 2022 | −$3.44 | −$2.40 | +30.16% | $0.00 | — |
| Q3 2021 | Nov 12, 2021 | −$3.09 | −$6.90 | −123.64% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Jasper Therapeutics (JSPR) last report earnings?
Jasper Therapeutics last reported on Nov 10, 2025, covering fiscal Q3 2025.
Did JSPR beat earnings estimates?
Yes. Jasper Therapeutics reported EPS of −$1.13 for Q3 2025 against a −$1.21 estimate — a 6.99% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.